Cargando…
Serum microRNA-4297 is a sex-specific predictive biomarker of glioma grade and prognosis
BACKGROUND: Gliomas account for nearly 80% of brain cancers, tending to occur more frequently in men with adverse outcomes. Emerging microRNAs have been positioned as promising predictors for glioma's histological grade and prognosis. However, there have been few studies concerning the sex-bias...
Autores principales: | Xu, Wenshen, Huang, Liming, Xie, Bingsen, Yang, Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363699/ https://www.ncbi.nlm.nih.gov/pubmed/35968285 http://dx.doi.org/10.3389/fneur.2022.888221 |
Ejemplares similares
-
Effect of Food on the Pharmacokinetics of Senaparib (IMP4297) in Healthy Chinese Subjects
por: Meng, Xianmin, et al.
Publicado: (2022) -
MicroRNAs in the Diagnosis of Malignancy of Supratentorial Brain Gliomas and Prognosis of Disease Progression
por: Stupak, Evgeny V, et al.
Publicado: (2023) -
Circulating MicroRNAs as Promising Diagnostic Biomarkers for Patients With Glioma: A Meta-Analysis
por: He, Jimin, et al.
Publicado: (2021) -
Radiation Therapy for Grade 3 Gliomas: Correlation of MRI Findings With Prognosis
por: Mizumoto, Masashi, et al.
Publicado: (2021) -
Serum microRNA-210 as a potential noninvasive biomarker for the diagnosis and prognosis of glioma
por: Lai, N-s, et al.
Publicado: (2015)